HOME › DRUGS › EPOETIN THETA
ACTIVE SUBSTANCE / INN

EPOETIN THETA

Brand name(s): Eporatio, Ratioepo, Biopoin
EMA LISTED
APPLICATION WITHDRAWN
AUTHORISED
Anemia;Kidney Failure;Cancer
Kidney Failure, Chronic;Anemia;Cancer
ACTIVE SUBSTANCE
Epoetin Theta
REGULATORS
EMA
SPONSORS / MAH
Ratiopharm GmbH, Teva GmbH
TOTAL APPLICATIONS
3
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EporatioRatiopharm GmbHAuthorised29/10/2009Kidney Failure, Chronic;Anemia;Cancer
BiopoinTeva GmbHAuthorised23/10/2009Kidney Failure, Chronic;Anemia;Cancer
RatioepoRatiopharm GmbHApplication withdrawnAnemia;Kidney Failure;Cancer

FULL INTELLIGENCE ON EPOETIN THETA

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →